Skip to main content
You have permission to edit this article.
Edit
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

76.91 +1.11 (+1.46%)
Official Closing Price Updated: 4:10 PM EDT, May 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,439,972
Open 76.29
Bid (Size) 76.90 (1)
Ask (Size) 76.91 (8)
Prev. Close 75.80
Today's Range 76.08 - 77.25
52wk Range 53.22 - 78.17
Shares Outstanding 2,222,113,553
Dividend Yield 2.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Michael Burry Is Betting Against Apple: Here's The Size Of 'The Big Short' Investor's Stake
Michael Burry has been known to take large positions against companies he thinks are overvalued. 
Via Benzinga
Warren Buffett Stocks: Berkshire Hathaway Goes On Offense In Stock Market, Adds More Apple
Buffett's Berkshire added to Apple and Chevron during the Q1 sell-off. More details to come. 
Via Investor's Business Daily

Performance

YTD
+24.29%
+24.29%
1 Month
+0.21%
+0.21%
3 Month
+15.12%
+15.12%
6 Month
+29.00%
+29.00%
1 Year
+17.49%
+17.49%

More News

Read More
Bristol Myers Squibb Provides Update on CheckMate -901 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Patients with Unresectable or Metastatic Urothelial Carcinoma
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Q1 Earnings Surpass Street Expectations, Lowers FY22 Guidance
Via Benzinga
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
Via Talk Markets
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Via Benzinga
LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York
From Bristol Myers Squibb
Via Business Wire
BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology
Via Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
Via Benzinga
New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis
From Bristol Myers Squibb
Via Business Wire
The Top 10 Stocks Helping Warren Buffett Beat the Market
Via InvestorPlace
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Via Benzinga
Bristol-Myers: "Boring Is Good"
Via Talk Markets
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Peering Into Bristol-Myers Squibb's Recent Short Interest
Via Benzinga
Check Out What Whales Are Doing With BMY
Via Benzinga
Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference
From Bristol Myers Squibb
Via Business Wire
Bristol-Myers Squibb's Return On Capital Employed Overview
Via Benzinga
What 4 Analyst Ratings Have To Say About Bristol-Myers Squibb
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
Via Benzinga
Week In Review: I-Mab Files For Hong Kong SPAC IPO To Acquire Life Science Company
Via Talk Markets
Stock Market Volatile; Apple, Facebook, Amazon Are Key Earnings, Tesla CEO Elon Musk Buys Twitter: Weekly Review
Via Investor's Business Daily
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
Via Benzinga
Bristol Myers Squibb Dives As Generics, Revlimid Rivals Slam 2022 Outlook
Via Investor's Business Daily
Bristol-Myers Squibb: Q1 Earnings Insights
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.